The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue , 2013, Pages

  Kotwinski, Paul ^a,b   Smith, Gillian ^b   Sanders, Julie ^a   Ma, Louise ^a   Cooper, Jackie ^c   Thomas, Michael ^d   Jones, Alison ^c   Montgomery, Hugh E ^a   Pennell, Dudley J ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e Monty) G   (United Kingdom)

Author keywords

Anthracycline; Biomedical Research Unit; Poor Discriminator; Royal Brompton Hospital; Trastuzumab

Indexed keywords

EID: 85015802096     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-S1-O94     Document Type: Article

References (0)